Oral microbiome capsules for peanut allergy in teens
Part of Immune system & allergy clinical trials.
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 12–17 and you have peanut allergy signs on testing
- You must have had a supervised peanut allergy challenge or dose reaction in the specified way
- If you have asthma, your breathing test must be in a safe range (FEV1 at least 80%)
- You can swallow two empty capsules and you can do clinic visits and stool sample collection
- If you’re a sexually active female who could get pregnant, you must use effective birth control during the study
- You (and your guardian) can agree to the study and to follow-up by phone/email for side effects
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.
This study compares two types of peanut oral immunotherapy (a treatment that helps you build tolerance to peanuts) — one with standard peanuts and one with autoclaved (specially heat-treated) peanuts. It is for people with peanut allergy and aims to see which approach is safer and more effective.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.